AtriCure annual operating margin
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
AtriCure's operating margin was −1.77% for fiscal 2025.
View full AtriCure company overview| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −1.77% | +6.83 pp |
| 2024 | 2024-12-31 | −8.60% | −1.92 pp |
| 2023 | 2023-12-31 | −6.68% | +6.23 pp |
| 2022 | 2022-12-31 | −12.92% | −33.04 pp |
| 2021 | 2021-12-31 | 20.12% | +41.54 pp |
| 2020 | 2020-12-31 | −21.42% | −7.07 pp |
| 2019 | 2019-12-31 | −14.35% | −5.86 pp |
| 2018 | 2018-12-31 | −8.49% | +5.80 pp |
| 2017 | 2017-12-31 | −14.30% | +5.78 pp |
| 2016 | 2016-12-31 | −20.07% | +0.52 pp |
| 2015 | 2015-12-31 | −20.59% | −5.37 pp |
| 2014 | 2014-12-31 | −15.23% | −1.93 pp |
| 2013 | 2013-12-31 | −13.30% | −3.05 pp |
| 2012 | 2012-12-31 | −10.25% | −2.90 pp |
| 2011 | 2011-12-31 | −7.35% | −1.94 pp |
| 2010 | 2010-12-31 | −5.41% | +23.04 pp |
| 2009 | 2009-12-31 | −28.44% | — |
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | 6.29% | +10.84 pp |
| Q1 2026 | 2026-03-31 | 0.37% | +5.19 pp |
| Q4 2025 | 2025-12-31 | 1.77% | +13.46 pp |
| Q3 2025 | 2025-09-30 | 0.15% | +6.54 pp |
| Q2 2025 | 2025-06-30 | −4.55% | +1.62 pp |
| Q1 2025 | 2025-03-31 | −4.82% | +5.21 pp |
| Q4 2024 | 2024-12-31 | −11.69% | −3.55 pp |
| Q3 2024 | 2024-09-30 | −6.39% | +1.84 pp |
| Q2 2024 | 2024-06-30 | −6.17% | −2.06 pp |
| Q1 2024 | 2024-03-31 | −10.03% | −3.84 pp |
| Q4 2023 | 2023-12-31 | −8.14% | −3.44 pp |
| Q3 2023 | 2023-09-30 | −8.23% | +4.65 pp |
| Q2 2023 | 2023-06-30 | −4.11% | +12.05 pp |
| Q1 2023 | 2023-03-31 | −6.18% | +12.79 pp |
| Q4 2022 | 2022-12-31 | −4.70% | +12.38 pp |
| Q3 2022 | 2022-09-30 | −12.88% | −152.92 pp |
| Q2 2022 | 2022-06-30 | −16.16% | +4.96 pp |
| Q1 2022 | 2022-03-31 | −18.97% | +7.82 pp |
| Q4 2021 | 2021-12-31 | −17.08% | +13.25 pp |
| Q3 2021 | 2021-09-30 | 140.04% | +147.32 pp |
| Q2 2021 | 2021-06-30 | −21.12% | −3.28 pp |
| Q1 2021 | 2021-03-31 | −26.80% | +2.24 pp |
| Q4 2020 | 2020-12-31 | −30.32% | −5.33 pp |
| Q3 2020 | 2020-09-30 | −7.29% | +7.97 pp |
| Q2 2020 | 2020-06-30 | −17.84% | −11.33 pp |
| Q1 2020 | 2020-03-31 | −29.04% | −19.18 pp |
| Q4 2019 | 2019-12-31 | −24.99% | −20.06 pp |
| Q3 2019 | 2019-09-30 | −15.26% | −3.15 pp |
| Q2 2019 | 2019-06-30 | −6.52% | −8.37 pp |
| Q1 2019 | 2019-03-31 | −9.86% | +10.21 pp |
| Q4 2018 | 2018-12-31 | −4.93% | −0.29 pp |
| Q3 2018 | 2018-09-30 | −12.11% | +4.13 pp |
| Q2 2018 | 2018-06-30 | 1.85% | +15.90 pp |
| Q1 2018 | 2018-03-31 | −20.07% | +3.30 pp |
| Q4 2017 | 2017-12-31 | −4.64% | +14.06 pp |
| Q3 2017 | 2017-09-30 | −16.24% | +0.15 pp |
| Q2 2017 | 2017-06-30 | −14.05% | +5.45 pp |
| Q1 2017 | 2017-03-31 | −23.36% | +2.85 pp |
| Q4 2016 | 2016-12-31 | −18.70% | +10.94 pp |
| Q3 2016 | 2016-09-30 | −16.40% | +3.10 pp |
| Q2 2016 | 2016-06-30 | −19.50% | −4.72 pp |
| Q1 2016 | 2016-03-31 | −26.21% | −9.00 pp |
| Q4 2015 | 2015-12-31 | −29.64% | −13.39 pp |
| Q3 2015 | 2015-09-30 | −19.50% | −16.49 pp |
| Q2 2015 | 2015-06-30 | −14.79% | −4.03 pp |
| Q1 2015 | 2015-03-31 | −17.21% | +14.68 pp |
| Q4 2014 | 2014-12-31 | −16.25% | +5.86 pp |
| Q3 2014 | 2014-09-30 | −3.01% | +9.97 pp |
| Q2 2014 | 2014-06-30 | −10.76% | −2.74 pp |
| Q1 2014 | 2014-03-31 | −31.90% | −22.63 pp |
| Q4 2013 | 2013-12-31 | −22.11% | −12.02 pp |
| Q3 2013 | 2013-09-30 | −12.98% | +2.69 pp |
| Q2 2013 | 2013-06-30 | −8.02% | −0.80 pp |
| Q1 2013 | 2013-03-31 | −9.26% | −0.70 pp |
| Q4 2012 | 2012-12-31 | −10.09% | +0.02 pp |
| Q3 2012 | 2012-09-30 | −15.67% | −7.85 pp |
| Q2 2012 | 2012-06-30 | −7.23% | −2.63 pp |
| Q1 2012 | 2012-03-31 | −8.56% | −1.69 pp |
| Q4 2011 | 2011-12-31 | −10.11% | −4.37 pp |
| Q3 2011 | 2011-09-30 | −7.82% | −4.77 pp |
| Q2 2011 | 2011-06-30 | −4.59% | — |
| Q1 2011 | 2011-03-31 | −6.87% | — |
| Q3 2010 | 2010-09-30 | −5.74% | — |
| Q2 2010 | 2010-06-30 | −3.05% | — |
Over the last five reported fiscal years, AtriCure's operating margin increased from −21.42% to −1.77%, a change of +19.65 percentage points. The latest reported quarter, Q2 2026, shows 6.29%.
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review AtriCure filings at SEC.gov ↗